DOCSLIB.ORG

Mechanism Independent − Via a Caspase-1 Β Bioactive IL-1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Inhibition of Histone Deacetylases Permits Lipopolysaccharide-Mediated Secretion of Bioactive IL-1β via a Caspase-1−Independent Mechanism This information is current as of September 28, 2021. Dominik Stammler, Tatjana Eigenbrod, Sarah Menz, Julia S. Frick, Matthew J. Sweet, Melanie R. Shakespear, Jonathan Jantsch, Isabel Siegert, Sabine Wölfle, Julian D. Langer, Ina Oehme, Liliana Schaefer, Andre Fischer, Judith Knievel, Klaus Heeg, Alexander H. Dalpke and Konrad A. Bode Downloaded from J Immunol published online 30 October 2015 http://www.jimmunol.org/content/early/2015/10/30/jimmun ol.1501195 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2015/10/30/jimmunol.150119 Material 5.DCSupplemental Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 28, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published October 30, 2015, doi:10.4049/jimmunol.1501195 The Journal of Immunology Inhibition of Histone Deacetylases Permits Lipopolysaccharide-Mediated Secretion of Bioactive IL-1b via a Caspase-1–Independent Mechanism Dominik Stammler,* Tatjana Eigenbrod,* Sarah Menz,† Julia S. Frick,† Matthew J. Sweet,‡ Melanie R. Shakespear,‡ Jonathan Jantsch,x,{ Isabel Siegert,{ Sabine Wo¨lfle,* Julian D. Langer,‖ Ina Oehme,# Liliana Schaefer,** Andre Fischer,†† Judith Knievel,‡‡ Klaus Heeg,* Alexander H. Dalpke,* and Konrad A. Bode* Histone deacetylase (HDAC) inhibitors (HDACi) are clinically approved anticancer drugs that have important immune- modulatory properties. We report the surprising finding that HDACi promote LPS-induced IL-1b processing and secretion in Downloaded from human and murine dendritic cells and murine macrophages. HDACi/LPS-induced IL-1b maturation and secretion kinetics differed completely from those observed upon inflammasome activation. Moreover, this pathway of IL-1b secretion was depen- dent on caspase-8 but was independent of the inflammasome components NACHT, LRR, and PYD domains-containing protein 3, apoptosis-associated speck-like protein containing a carboxyl-terminal caspase-recruitment domain, and caspase-1. Genetic stud- ies excluded HDAC6 and HDAC10 as relevant HDAC targets in this pathway, whereas pharmacological inhibitor studies impli- cated the involvement of HDAC11. Treatment of mice with HDACi in a dextran sodium sulfate–induced colitis model resulted in a http://www.jimmunol.org/ strong increase in intestinal IL-1b, confirming that this pathway is also operative in vivo. Thus, in addition to the conventional inflammasome-dependent IL-1b cleavage pathway, dendritic cells and macrophages are capable of generating, secreting, and processing bioactive IL-1b by a novel, caspase-8–dependent mechanism. Given the widespread interest in the therapeutic target- ing of IL-1b, as well as the use of HDACi for anti-inflammatory applications, these findings have substantial clinical implications. The Journal of Immunology, 2015, 195: 000–000. ppropriate regulation of local immunity is a prerequisite APC, such as macrophages and dendritic cells (DC) respond, for the maintenance of local tissue homeostasis, and depending on the stimulus, with the secretion of several in- A dysregulated innate immunity can result in acute or flammatory cytokines, including TNF-a, IL-12p40, IL-6, and by guest on September 28, 2021 chronic inflammation. Both hematopoietic and nonhematopoietic IL-1b (1). cells of the innate immune system recognize pathogen- and The IL-1b cytokine exhibits diverse biological activities and damage-associated molecular patterns via a variety of pattern- plays a central role in acute and chronic inflammation. Because of recognition receptors, including the TLR, nucleotide-binding oligo- its potent proinflammatory effects, IL-1b production is tightly merization domain protein-like receptors (NLR), such as nucleotide- regulated. At least two stimuli are needed for the secretion of binding oligomerization domain-containing protein (NOD)1 and bioactive IL-1b: a first stimulus (e.g., a TLR ligand) is required for NOD2 and the inflammasome-associated NLRP/NLRC sensor inducible expression of pro–IL-1b and priming of the inflamma- proteins, C-type lectin receptors, and Rig-I–like receptors (1). some, after which a second signaling event is necessary for pro–IL- Stimulation of these receptors results in cellular activation and 1b processing and the secretion of active IL-1b (2, 3). Pro–IL-1b the tailored release of a panel of cytokines and chemokines that itself is biologically inactive and requires proteolytic cleavage to is appropriate to the class of pathogen encountered. Professional enable secretion and biological responses. Classically, pro–IL-1b is *Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg Address correspondence and reprint requests to Dr. Konrad A. Bode, Department of University Hospital, Heidelberg 69120, Germany; †Institute of Medical Microbiology Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hos- and Hygiene, University of Tubingen,€ Tubingen€ 70276, Germany; ‡Institute for Mo- pital, Im Neuenheimer Feld 324, Heidelberg 69120, Germany. E-mail address: lecular Bioscience, University of Queensland, Brisbane, St. Lucia, Queensland 4072, [email protected] Australia; xInstitute of Clinical Microbiology and Hygiene, University Hospital Regens- { The online version of this article contains supplemental material. burg, Regensburg 93053, Germany; Institute of Microbiology, University of Erlangen- Nuremberg, Erlangen 91054, Germany; ‖Department of Molecular Membrane Biology, Abbreviations used in this article: ASC, apoptosis-associated speck-like protein con- Max-Planck-Institute for Biophysics, Frankfurt 60438, Germany; #Clinical Cooperation taining a carboxyl-terminal caspase-recruitment domain; BMDC, bone marrow–de- Unit Pediatric Oncology, German Cancer Research Center, Heidelberg 69120, Ger- rived DC; BMDM, BM-derived macrophage; DC, dendritic cell; DSS, dextran many; **Institute of Pharmacology, Goethe University Frankfurt, Frankfurt 60590, sodium sulfate; HATi, histone acetyltransferase inhibitor; HDAC, histone deacety- Germany; ††German Center for Neurodegenerative Diseases, Department of Psychiatry lase; HDACi, HDAC inhibitor; IQ, imiquimod; KO, knockout; LTA, lipoteichoic and Psychotherapy, University Medical Center Go¨ttingen, Go¨ttingen 37077, Germany; acid; MDP, muramyl dipeptide; NLR, nucleotide-binding oligomerization domain and ‡‡Department of Gastroenterology, Hepatology, and Infectious Disease, University protein-like receptor; NLRP3, NACHT, LRR, and PYD domains-containing protein Hospital, Heinrich Heine University of Dusseldorf,€ Dusseldorf€ 40225, Germany 3; NOD, nucleotide-binding oligomerization domain-containing protein; PD106, pimelic diphenylamide 106; p(I:C), poly(deoxyinosinic-deoxycytidylic) acid; poly ORCIDs: 0000-0003-0974-7402 (J.K.); 0000-0001-9085-965X (K.A.B.). (I:C), polyinosinic-polycytidylic acid; SAHA, suberanilohydroxamic acid; siRNA, Received for publication June 3, 2015. Accepted for publication October 5, 2015. small interfering RNA; TRIF, TIR domain-containing adapter-inducing IFN-b; TSA, trichostatin A; WT, wild-type. This work was supported by German Research Foundation Grants BO 3673/1-1 (to K.A.B.) and INST 114089/4-1 FUGG (to K.H.). M.J.S. is supported by a National Ó Health and Medical Research Council of Australia Senior Research Fellowship Copyright 2015 by The American Association of Immunologists, Inc. 0022-1767/15/$25.00 (APP1003470). www.jimmunol.org/cgi/doi/10.4049/jimmunol.1501195 2 HDACi PERMITS LPS-MEDIATED SECRETION OF BIOACTIVE IL-1b cleaved by caspase-1. Stimulation of primed cells with damage- Cell Signaling Technology (Danvers, MA). Acetylated histone H3 was associated molecular patterns, such as ATP and urate crystals, or detected by an Ab purchased from Active Motif (Carlsbad, CA). The Ab pore-forming toxins, like nigericin, results in the assembly of a against b-actin was from Upstate Biotechnologies (Lake Placid, NY). MyD88-, apoptosis-associated speck-like protein containing a carboxy- large protein complex, the so-called “inflammasome,” which is terminal caspase-recruitment domain (ASC)-, NACHT, LRR, and PYD responsible for activation of caspase-1. Despite a predominant role domains-containing protein 3 (NLRP3)-, HDAC6-, cathepsin B–, cathep- for caspase-1 in pro–IL-1b cleavage, other enzymes, such as sin S–, granzyme A–, granzyme B–, IL-1b–, and caspase-1/11–knockout neutrophil elastase (4), proteinase 3 (5), chymase, cathepsin G (6), (KO) mice were described (18–27); lps2 mutant strains carry a mutation in TIR domain-containing adapter-inducing IFN-b (TRIF) (28). HDAC10- granzyme A (7), the matrix metalloproteinases stromelysin 1, KO mice were purchased from The Jackson Laboratory
Recommended publications
  • An Overview of the Role of Hdacs in Cancer Immunotherapy

    An Overview of the Role of Hdacs in Cancer Immunotherapy

    International Journal of Molecular Sciences Review Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy Debarati Banik, Sara Moufarrij and Alejandro Villagra * Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, 800 22nd St NW, Suite 8880, Washington, DC 20052, USA; [email protected] (D.B.); [email protected] (S.M.) * Correspondence: [email protected]; Tel.: +(202)-994-9547 Received: 22 March 2019; Accepted: 28 April 2019; Published: 7 May 2019 Abstract: Long-standing efforts to identify the multifaceted roles of histone deacetylase inhibitors (HDACis) have positioned these agents as promising drug candidates in combatting cancer, autoimmune, neurodegenerative, and infectious diseases. The same has also encouraged the evaluation of multiple HDACi candidates in preclinical studies in cancer and other diseases as well as the FDA-approval towards clinical use for specific agents. In this review, we have discussed how the efficacy of immunotherapy can be leveraged by combining it with HDACis. We have also included a brief overview of the classification of HDACis as well as their various roles in physiological and pathophysiological scenarios to target key cellular processes promoting the initiation, establishment, and progression of cancer. Given the critical role of the tumor microenvironment (TME) towards the outcome of anticancer therapies, we have also discussed the effect of HDACis on different components of the TME. We then have gradually progressed into examples of specific pan-HDACis, class I HDACi, and selective HDACis that either have been incorporated into clinical trials or show promising preclinical effects for future consideration.
  • Inflammasome Activation-Induced Hypercoagulopathy

    Inflammasome Activation-Induced Hypercoagulopathy

    cells Review Inflammasome Activation-Induced Hypercoagulopathy: Impact on Cardiovascular Dysfunction Triggered in COVID-19 Patients Lealem Gedefaw, Sami Ullah, Polly H. M. Leung , Yin Cai, Shea-Ping Yip * and Chien-Ling Huang * Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China; [email protected] (L.G.); [email protected] (S.U.); [email protected] (P.H.M.L.); [email protected] (Y.C.) * Correspondence: [email protected] (S.-P.Y.); [email protected] (C.-L.H.) Abstract: Coronavirus disease 2019 (COVID-19) is the most devastating infectious disease in the 21st century with more than 2 million lives lost in less than a year. The activation of inflammasome in the host infected by SARS-CoV-2 is highly related to cytokine storm and hypercoagulopathy, which significantly contribute to the poor prognosis of COVID-19 patients. Even though many studies have shown the host defense mechanism induced by inflammasome against various viral infections, mechanistic interactions leading to downstream cellular responses and pathogenesis in COVID-19 remain unclear. The SARS-CoV-2 infection has been associated with numerous cardiovascular disor- ders including acute myocardial injury, myocarditis, arrhythmias, and venous thromboembolism. The inflammatory response triggered by the activation of NLRP3 inflammasome under certain car- diovascular conditions resulted in hyperinflammation or the modulation of angiotensin-converting enzyme 2 signaling pathways. Perturbations of several target cells and tissues have been described in inflammasome activation, including pneumocytes, macrophages, endothelial cells, and dendritic cells. Citation: Gedefaw, L.; Ullah, S.; Leung, P.H.M.; Cai, Y.; Yip, S.-P.; The interplay between inflammasome activation and hypercoagulopathy in COVID-19 patients is an Huang, C.-L.
  • NLRP6 Induces Pyroptosis by Activation of Caspase-1 in Gingival

    NLRP6 Induces Pyroptosis by Activation of Caspase-1 in Gingival

    JDRXXX10.1177/0022034518775036Journal of Dental ResearchNLRP6 Induces Pyroptosis 775036research-article2018 Research Reports: Biological Journal of Dental Research 2018, Vol. 97(12) 1391 –1398 © International & American Associations NLRP6 Induces Pyroptosis by Activation for Dental Research 2018 Article reuse guidelines: of Caspase-1 in Gingival Fibroblasts sagepub.com/journals-permissions DOI:https://doi.org/10.1177/0022034518775036 10.1177/0022034518775036 journals.sagepub.com/home/jdr W. Liu1* , J. Liu1*, W. Wang1, Y. Wang2,3, and X. Ouyang1 Abstract NLRP6, a member of the nucleotide-binding domain, leucine-rich repeat-containing (NLR) innate immune receptor family, has been reported to participate in inflammasome formation. Activation of inflammasome triggers a caspase-1–dependent programming cell death called pyroptosis. However, whether NLRP6 induces pyroptosis has not been investigated. In this study, we showed that NLRP6 overexpression activated caspase-1 and gasdermin-D and then induced pyroptosis of human gingival fibroblasts, resulting in release of proinflammatory mediators interleukin (IL)–1β and IL-18. Moreover, NLRP6 was highly expressed in gingival tissue of periodontitis compared with healthy controls. Porphyromonas gingivalis, which is a commensal bacterium and has periodontopathic potential, induced pyroptosis of gingival fibroblasts by activation of NLRP6. Together, we, for the first time, identified that NLRP6 could induce pyroptosis of gingival fibroblasts by activation of caspase-1 and may play a role in periodontitis. Keywords: periodontitis, pattern recognition receptors, cell death, Porphyromonas gingivalis, inflammasomes, flow cytometry Introduction have been demonstrated to participate in periodontitis (Huang et al. 2015; Chaves de Souza et al. 2016; Marchesan et al. Pyroptosis is a newly identified type of programmed cell death 2016).
  • The Intestinal Parasite Cryptosporidium Is Controlled by an Enterocyte Intrinsic Inflammasome That Depends on NLRP6

    The Intestinal Parasite Cryptosporidium Is Controlled by an Enterocyte Intrinsic Inflammasome That Depends on NLRP6

    The intestinal parasite Cryptosporidium is controlled by an enterocyte intrinsic inflammasome that depends on NLRP6 Adam Saterialea,1, Jodi A. Gullicksruda, Julie B. Engilesa, Briana I. McLeoda, Emily M. Kuglera, Jorge Henao-Mejiab,c, Ting Zhoud, Aaron M. Ringd, Igor E. Brodskya, Christopher A. Huntera, and Boris Striepena,2 aDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104; bDepartment of Pathology and Laboratory Medicine, Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104; cDivision of Protective Immunity, Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, Philadelphia, PA 19104; and dDepartment of Immunology, Yale School of Medicine, Yale University, New Haven, CT 06519 Edited by Stephen M. Beverley, Washington University School of Medicine, St. Louis, MO, and approved December 1, 2020 (received for review April 24, 2020) The apicomplexan parasite Cryptosporidium infects the intestinal Murine infection with C. tyzzeri resembles human cryptospo- epithelium. While infection is widespread around the world, chil- ridiosis in location, pathology, and resolution and provides an dren in resource-poor settings suffer a disproportionate disease important tool to define the host and parasite factors that burden. Cryptosporidiosis is a leading cause of diarrheal disease, determine the outcome of infection and to identify the im- responsible for mortality and stunted growth in children. CD4 mune
  • NOD-Like Receptors in the Eye: Uncovering Its Role in Diabetic Retinopathy

    NOD-Like Receptors in the Eye: Uncovering Its Role in Diabetic Retinopathy

    International Journal of Molecular Sciences Review NOD-like Receptors in the Eye: Uncovering Its Role in Diabetic Retinopathy Rayne R. Lim 1,2,3, Margaret E. Wieser 1, Rama R. Ganga 4, Veluchamy A. Barathi 5, Rajamani Lakshminarayanan 5 , Rajiv R. Mohan 1,2,3,6, Dean P. Hainsworth 6 and Shyam S. Chaurasia 1,2,3,* 1 Ocular Immunology and Angiogenesis Lab, University of Missouri, Columbia, MO 652011, USA; [email protected] (R.R.L.); [email protected] (M.E.W.); [email protected] (R.R.M.) 2 Department of Biomedical Sciences, University of Missouri, Columbia, MO 652011, USA 3 Ophthalmology, Harry S. Truman Memorial Veterans’ Hospital, Columbia, MO 652011, USA 4 Surgery, University of Missouri, Columbia, MO 652011, USA; [email protected] 5 Singapore Eye Research Institute, Singapore 169856, Singapore; [email protected] (V.A.B.); [email protected] (R.L.) 6 Mason Eye Institute, School of Medicine, University of Missouri, Columbia, MO 652011, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-573-882-3207 Received: 9 December 2019; Accepted: 27 January 2020; Published: 30 January 2020 Abstract: Diabetic retinopathy (DR) is an ocular complication of diabetes mellitus (DM). International Diabetic Federations (IDF) estimates up to 629 million people with DM by the year 2045 worldwide. Nearly 50% of DM patients will show evidence of diabetic-related eye problems. Therapeutic interventions for DR are limited and mostly involve surgical intervention at the late-stages of the disease. The lack of early-stage diagnostic tools and therapies, especially in DR, demands a better understanding of the biological processes involved in the etiology of disease progression.
  • Examining the Role of Non-Canonical NOD-Like Receptors and Inflammasomes in Inflammation and Disease

    Examining the Role of Non-Canonical NOD-Like Receptors and Inflammasomes in Inflammation and Disease

    University of Calgary PRISM: University of Calgary's Digital Repository Graduate Studies The Vault: Electronic Theses and Dissertations 2018-03-21 Examining the Role of Non-Canonical NOD-like Receptors and Inflammasomes in Inflammation and Disease Platnich, Jaye Matthew Platnich, J. M. (2018). Examining the Role of Non-Canonical NOD-like Receptors and Inflammasomes in Inflammation and Disease (Unpublished doctoral thesis). University of Calgary, Calgary, AB. doi:10.11575/PRISM/31757 http://hdl.handle.net/1880/106465 doctoral thesis University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission. Downloaded from PRISM: https://prism.ucalgary.ca UNIVERSITY OF CALGARY Examining the Role of Non-Canonical NOD-like Receptors and Inflammasomes in Inflammation and Disease by Jaye Matthew Platnich A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY GRADUATE PROGRAM IN IMMUNOLOGY CALGARY, ALBERTA MARCH, 2018 © Jaye Matthew Platnich 2018 Abstract The NOD-like Receptors (NLRs) are a family of pattern recognition receptors known to regulate a variety of immune signaling pathways. A substantial portion of NLR research focuses on the pyrin domain-containing NLRP subfamily. The canonical NLRPs are inflammasome-forming proteins responsible for the activation of caspase-1 and the maturation and secretion of the pro-inflammatory cytokines IL-1β and IL-18.
  • Hr23b Expression Is a Potential Predictive Biomarker for HDAC Inhibitor Treatment in Mesenchymal Tumours and Is Associated with Response to Vorinostat

    Hr23b Expression Is a Potential Predictive Biomarker for HDAC Inhibitor Treatment in Mesenchymal Tumours and Is Associated with Response to Vorinostat

    The Journal of Pathology: Clinical Research J Path: Clin Res April 2016; 2: 59–71 Original Article Published online 23 December 2015 in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/cjp2.35 HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat Michaela Angelika Ihle,1 Sabine Merkelbach-Bruse,1 Wolfgang Hartmann,1,2 Sebastian Bauer,3 Nancy Ratner,4 Hiroshi Sonobe,5 Jun Nishio,6 Olle Larsson,7 Pierre A˚ man,8 Florence Pedeutour,9 Takahiro Taguchi,10 Eva Wardelmann,1,2 Reinhard Buettner1 and Hans-Ulrich Schildhaus1,11* 1 Institute of Pathology, University Hospital Cologne, Cologne, Germany 2 Gerhard Domagk Institute of Pathology, University Hospital M€unster, M€unster, Germany 3 Sarcoma Center, West German Cancer Center, University of Essen, Essen, Germany 4 US Department of Pediatrics, Cincinnati Children’s Hospital Medical Centre, Cincinnati, OH, USA 5 Department of Laboratory Medicine, Chugoku Central Hospital, Fukuyama, Hiroshima, Japan 6 Faculty of Medicine, Department of Orthopaedic Surgery, Fukuoka University, Fukuoka, Japan 7 Department of Oncology and Pathology, The Karolinska Institute, Stockholm, Sweden 8 Sahlgrenska Cancer Centre, University of Gothenburg, Gothenburg, Sweden 9 Faculty of Medicine, Laboratory of Genetics of Solid Tumours, Institute for Research on Cancer and Aging, Nice, France 10 Division of Human Health & Medical Science, Graduate School of Kuroshio Science, Kochi University Nankoku, Kochi, Japan 11 Institute of Pathology, University Hospital G€ottingen, G€ottingen, Germany *Correspondence to: Hans-Ulrich Schildhaus,Institute of Pathology,University Hospital G€ottingen,Robert-Koch-Strasse40,D-37075G€ottingen, Germany.e-mail: [email protected] Abstract Histone deacetylases (HDAC) are key players in epigenetic regulation of gene expression and HDAC inhibitor (HDACi) treatment seems to be a promising anticancer therapy in many human tumours, including soft tissue sar- comas.
  • ATP-Binding and Hydrolysis in Inflammasome Activation

    ATP-Binding and Hydrolysis in Inflammasome Activation

    molecules Review ATP-Binding and Hydrolysis in Inflammasome Activation Christina F. Sandall, Bjoern K. Ziehr and Justin A. MacDonald * Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6, Canada; [email protected] (C.F.S.); [email protected] (B.K.Z.) * Correspondence: [email protected]; Tel.: +1-403-210-8433 Academic Editor: Massimo Bertinaria Received: 15 September 2020; Accepted: 3 October 2020; Published: 7 October 2020 Abstract: The prototypical model for NOD-like receptor (NLR) inflammasome assembly includes nucleotide-dependent activation of the NLR downstream of pathogen- or danger-associated molecular pattern (PAMP or DAMP) recognition, followed by nucleation of hetero-oligomeric platforms that lie upstream of inflammatory responses associated with innate immunity. As members of the STAND ATPases, the NLRs are generally thought to share a similar model of ATP-dependent activation and effect. However, recent observations have challenged this paradigm to reveal novel and complex biochemical processes to discern NLRs from other STAND proteins. In this review, we highlight past findings that identify the regulatory importance of conserved ATP-binding and hydrolysis motifs within the nucleotide-binding NACHT domain of NLRs and explore recent breakthroughs that generate connections between NLR protein structure and function. Indeed, newly deposited NLR structures for NLRC4 and NLRP3 have provided unique perspectives on the ATP-dependency of inflammasome activation. Novel molecular dynamic simulations of NLRP3 examined the active site of ADP- and ATP-bound models. The findings support distinctions in nucleotide-binding domain topology with occupancy of ATP or ADP that are in turn disseminated on to the global protein structure.
  • Supplemental Information Vesicular Glutamate Transporters Use Flexible Anion and Cation Binding Sites for Efficient Accumulation

    Supplemental Information Vesicular Glutamate Transporters Use Flexible Anion and Cation Binding Sites for Efficient Accumulation

    Neuron, Volume 84 Supplemental Information Vesicular Glutamate Transporters Use Flexible Anion and Cation Binding Sites for Efficient Accumulation of Neurotransmitter Julia Preobraschenski, Johannes-Friedrich Zander, Toshiharu Suzuki, Gudrun Ahnert-Hilger, and Reinhard Jahn SUPPLEMENTAL INFORMATION SUPPLEMENTAL FIGURES Figure S1: Cl- dependence of VGLUT-mediated glutamate uptake is independent of the isoform and does not require the Cl- channel ClC3, related to Figure 1. A: Cl-- dependence of glutamate uptake by SV isolated from wild type, VGLUT1-/-, or ClC3-/- mice. Data represent FCCP-sensitive uptake and are normalized to uptake at 4 mM chloride of the respective wild type.* B: Glutamate uptake by SV immunoisolated from rat brain using antibodies specific for VGLUT 1 or 2, respectively. The immunoisolated vesicles are highly enriched for their respective antigens, with only very limited overlap (Zander et al., 2010). Values are expressed as nmol/mg protein.* (*n=1). Figure S2: Characterization of proteoliposomes containing purified recombinant VGLUT1 and the proton ATPase TFoF1, related to Figure 2. A: Coomassie Blue-stained SDS-polyacrylamide gels (10%) of the purified proteins (5µg protein/lane) and an immunoblot for VGLUT1 (1µg). B: After reconstitution, VGLUT1 is predominantly oriented with the cytoplasmic side facing outward. VGLUT1 containing an N-terminal streptavidin binding peptide tag was reconstituted in liposomes and incubated with TEV protease (TEV) in the absence or presence of the detergent n-Octyl-β-D- glucopyranoside
  • Histone Deacetylase 3 As a Novel Therapeutic Target in Multiple Myeloma

    Histone Deacetylase 3 As a Novel Therapeutic Target in Multiple Myeloma

    Leukemia (2014) 28, 680–689 & 2014 Macmillan Publishers Limited All rights reserved 0887-6924/14 www.nature.com/leu ORIGINAL ARTICLE Histone deacetylase 3 as a novel therapeutic target in multiple myeloma J Minami1,4, R Suzuki1,4, R Mazitschek2, G Gorgun1, B Ghosh2,3, D Cirstea1,YHu1, N Mimura1, H Ohguchi1, F Cottini1, J Jakubikova1, NC Munshi1, SJ Haggarty3, PG Richardson1, T Hideshima1 and KC Anderson1 Histone deacetylases (HDACs) represent novel molecular targets for the treatment of various types of cancers, including multiple myeloma (MM). Many HDAC inhibitors have already shown remarkable antitumor activities in the preclinical setting; however, their clinical utility is limited because of unfavorable toxicities associated with their broad range HDAC inhibitory effects. Isoform- selective HDAC inhibition may allow for MM cytotoxicity without attendant side effects. In this study, we demonstrated that HDAC3 knockdown and a small-molecule HDAC3 inhibitor BG45 trigger significant MM cell growth inhibition via apoptosis, evidenced by caspase and poly (ADP-ribose) polymerase cleavage. Importantly, HDAC3 inhibition downregulates phosphorylation (tyrosine 705 and serine 727) of signal transducers and activators of transcription 3 (STAT3). Neither interleukin-6 nor bone marrow stromal cells overcome this inhibitory effect of HDAC3 inhibition on phospho-STAT3 and MM cell growth. Moreover, HDAC3 inhibition also triggers hyperacetylation of STAT3, suggesting crosstalk signaling between phosphorylation and acetylation of STAT3. Importantly, inhibition of HDAC3, but not HDAC1 or 2, significantly enhances bortezomib-induced cytotoxicity. Finally, we confirm that BG45 alone and in combination with bortezomib trigger significant tumor growth inhibition in vivo in a murine xenograft model of human MM.
  • Impact of the Microbial Derived Short Chain Fatty Acid Propionate on Host Susceptibility to Bacterial and Fungal Infections in Vivo

    Impact of the Microbial Derived Short Chain Fatty Acid Propionate on Host Susceptibility to Bacterial and Fungal Infections in Vivo

    www.nature.com/scientificreports OPEN Impact of the microbial derived short chain fatty acid propionate on host susceptibility to bacterial and Received: 01 July 2016 Accepted: 02 November 2016 fungal infections in vivo Published: 29 November 2016 Eleonora Ciarlo1,*, Tytti Heinonen1,*, Jacobus Herderschee1, Craig Fenwick2, Matteo Mombelli1, Didier Le Roy1 & Thierry Roger1 Short chain fatty acids (SCFAs) produced by intestinal microbes mediate anti-inflammatory effects, but whether they impact on antimicrobial host defenses remains largely unknown. This is of particular concern in light of the attractiveness of developing SCFA-mediated therapies and considering that SCFAs work as inhibitors of histone deacetylases which are known to interfere with host defenses. Here we show that propionate, one of the main SCFAs, dampens the response of innate immune cells to microbial stimulation, inhibiting cytokine and NO production by mouse or human monocytes/ macrophages, splenocytes, whole blood and, less efficiently, dendritic cells. In proof of concept studies, propionate neither improved nor worsened morbidity and mortality parameters in models of endotoxemia and infections induced by gram-negative bacteria (Escherichia coli, Klebsiella pneumoniae), gram-positive bacteria (Staphylococcus aureus, Streptococcus pneumoniae) and Candida albicans. Moreover, propionate did not impair the efficacy of passive immunization and natural immunization. Therefore, propionate has no significant impact on host susceptibility to infections and the establishment of protective anti-bacterial responses. These data support the safety of propionate- based therapies, either via direct supplementation or via the diet/microbiota, to treat non-infectious inflammation-related disorders, without increasing the risk of infection. Host defenses against infection rely on innate immune cells that sense microbial derived products through pattern recognition receptors (PRRs) such as toll-like receptors (TLRs), c-type lectins, NOD-like receptors, RIG-I-like receptors and cytosolic DNA sensors.
  • Optogenetic Visualization of Presynaptic Tonic Inhibition of Cerebellar Parallel Fibers

    Optogenetic Visualization of Presynaptic Tonic Inhibition of Cerebellar Parallel Fibers

    Optogenetic Visualization of Presynaptic Tonic Inhibition of Cerebellar Parallel Fibers The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Berglund, K. et al. “Optogenetic Visualization of Presynaptic Tonic Inhibition of Cerebellar Parallel Fibers.” Journal of Neuroscience 36, 21 (May 2016): 5709–5723 © 2016 The Author(s) As Published http://dx.doi.org/10.1523/JNEUROSCI.4366-15.2016 Publisher Society for Neuroscience Version Final published version Citable link http://hdl.handle.net/1721.1/112258 Terms of Use Creative Commons Attribution 4.0 International License Detailed Terms http://creativecommons.org/licenses/by/4.0/ The Journal of Neuroscience, May 25, 2016 • 36(21):5709–5723 • 5709 Cellular/Molecular Optogenetic Visualization of Presynaptic Tonic Inhibition of Cerebellar Parallel Fibers X Ken Berglund,1,2* Lei Wen,3,4,5* Robert L. Dunbar,1 Guoping Feng,1 and XGeorge J. Augustine3,4,5,6 1Department of Neurobiology, Duke University Medical Center, Durham, North Carolina 27710, 2Departments of Neurosurgery and Anesthesiology, Emory University School of Medicine, Atlanta, Georgia 30322, 3Center for Functional Connectomics, Korea Institute of Science and Technology, Seoul 136-791, Republic of Korea, 4Lee Kong Chian School of Medicine, Nanyang Technological University, Research Techno Plaza, Singapore 637553 Singapore, 5Institute of Molecular and Cell Biology, Singapore 138673, Singapore, and 6MBL, Woods Hole, Massachusetts 02543 Tonic inhibition was imaged in cerebellar granule cells of transgenic mice expressing the optogenetic chloride indicator, Clomeleon. Blockade of GABAA receptors substantially reduced chloride concentration in granule cells due to block of tonic inhibition. This indicates thattonicinhibitionisasignificantcontributortotherestingchlorideconcentrationofthesecells.Tonicinhibitionwasobservednotonly in granule cell bodies, but also in their axons, the parallel fibers (PFs).